Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Impact of Clinical Subgroup and Baseline Amyloid PET Centiloid Levels on Occurrence of ARIA in the Lecanemab Phase 3 Clarity AD Study in Early Alzheimer’s Disease

              Author:Sabbagh, Marwan   Li, David   Dhadda, Shobha   Hersch, Steven   Giorgi, Luigi   Matta, Andre   Irizarry, Michael   Kramer, Lynn   

              Session Name:P1: Aging, Dementia, Cognitive, and Behavioral Neurology: Diagnostic Imaging  

              Topic:Aging, Dementia, Cognitive, and Behavioral Neurology  

              Program Number:P1.007  

              Author Institution:Barrow Neurological Institute, Phoenix, AZ  Eisai Inc., Woodcliff Lake, NJ  Eisai Inc., Nutley, NJ  Eisai Co., Ltd., Hatfield, United Kingdom  Eisai, Inc., Nutley, NJ  

              Conjugal Synucleinopathies: A Clinicopathologic Study

              Author:Adler, Charles   Halverson, Matthew   Zhang, Nan   Chiu, Shannon   Shill, Holly   Driver-Dunckley, Erika   Mehta, Shyamal   Atri, Alireza   Caviness, John   Serrano, Geidy   Shprecher, David   Belden, Christine   Sabbagh, Marwan   Long, Kathy   Beach, Thomas   

              Session Name:P7: Movement Disorders: Parkinson's Disease Basic Science  

              Topic:Movement Disorders  

              Program Number:P7.014  

              Author Institution:Mayo Clinic Arizona, Scottsdale, AZ  N/A, San Diego, CA  Barrow Neurological Institute, Phoenix, AZ  Banner Sun Health Research Institute, Sun City, AZ  

              Safety Profile of Semaglutide in People Aged 55 Years and Over: Pooled Data from the PIONEER, SUSTAIN, and STEP Phase 3 Clinical Programmes

              Author:Sabbagh, Marwan   Boschini, Cristina   Cohen, Sharon   Fugger, Magnus   Jessen, Frank   Gerardo Martino, Gabriel   Pedersen, Sue   Solís Tarazona, Luis Rafael   Aroda, Vanita   

              Session Name:P11: Dementia and Behavioral Neurology: Treatments 2  

              Topic:Aging, Dementia, Cognitive, and Behavioral Neurology  

              Program Number:P11.014  

              Author Institution:Barrow Neurological Institute, Phoenix, AZ  Novo Nordisk A/S, Søborg, Denmark  Toronto Memory Program, Toronto, ON, Canada  University Hospital of Cologne, Cologne, Germany  C-ENDO Diabetes and Endocrinology Clinic, Calgary, AB, Canada  Brigham and Women'S Hospital, Harvard Medical School, Boston, MA